Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BioLineRx Ltd. Capital/Financing Update 2019

Feb 17, 2019

6692_rns_2019-02-17_8ce70429-d64d-443a-9e21-33292ac9c86d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: February 13,
2019 4:30 P.M.
Form: F-3
CIK: 0001498403
Company Name: BioLineRx Ltd.
File Number: 333-229021

More from BioLineRx Ltd.

Foreign Filer Report 2026
May 22
Regulatory Filings 2026
May 19
Report Publication Announcement 2026
May 19
Foreign Filer Report 2026
May 19
Foreign Filer Report 2026
Apr 28
Regulatory Filings 2026
Apr 28
Report Publication Announcement 2026
Apr 28
Regulatory Filings 2026
Mar 29
Report Publication Announcement 2026
Mar 29
Annual Report 2026
Mar 27
View all filings →